![]() ![]() We have engaged with Indaba on multiple occasions and anticipate that we will have further dialogue with them." While we appreciate Indaba's investment in TRHC, we want to ensure that the Board is able to fulfill its fiduciary duty to maximize the value of Tabula Rasa, which includes protecting TRHC from being controlled or acquired in a manner or at a price that are not in the best interests of our stockholders. Gordon Tunstall, Lead Independent Director, stated, "We are adopting this Rights Plan to protect the long-term value of all Tabula Rasa stockholders' investments in the Company. According to Indaba's filings with the SEC, they began buying shares in TRHC in April 2022. The Board of Directors resolved to adopt the Rights Plan following the Jfiling by Indaba Capital Management ("Indaba") of an amendment to its Schedule 13D, in which the firm disclosed that it has acquired a position that represents approximately 25% of the outstanding shares in TRHC. ("Tabula Rasa," "TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration stockholder rights plan ("Rights Plan") under which stockholders will receive rights to purchase a new series of preferred stock in certain circumstances. MOORESTOWN, N.J., J/PRNewswire/ - Tabula Rasa HealthCare, Inc.
0 Comments
Leave a Reply. |